written on 08.05.2014

Big surprise: Payers don't trust pharma. The fix? Risky trials and transparency


Just in case you need more evidence that U.S. payers and pharma companies are at loggerheads, check out Ernst & Young's latest report on the pharma industry. It shows that drugmakers have certain opinions about their products and prices–and the people who write the checks have an entirely different set.

Latest Reports